Pharmaceutical Technology

MAY 31, 2023

The collaboration will leverage the AI drug discovery solution to create a novel compound, which will be advanced by Lilly through clinical and commercial development. XtalPi’s ID4Inno small-molecule drug discovery platform helps to create and explore a target-specific mega chemical space, as well as identify a promising lead series.

Leads 111

Leads Pharmaceutical Patients 111

pharmaphorum

JANUARY 12, 2023

Other changes include a move from multiple lines of business to “one centralised product organisation with increasingly connected healthcare solutions,” according to the new CEO, who replaced company founder Andrew Conrad on 3rd January. Stephen Gillett.

Engineering 67

Engineering Patients FDA Sales 67

PM360

OCTOBER 28, 2022

It’s the same story outside of health systems as well: Mega-payers control vast healthcare empires encompassing both care delivery and data science. Despite the pandemic, $22 billion in healthcare mergers and acquisitions closed in the first three quarters of 2021. The four most frequently cited investment priorities are: 1.

Key account management 117

Key account management Pharma Management Pharma sales reps 117

PM360

AUGUST 29, 2022

While mega- and macro-influencers (500,000+ followers) have the most visibility, people tend to pay more attention to their closest connections. Similarly, services such as telemedicine and telehealth solutions will draw in tech-savvy Gen Zers. Embracing these technologies can expand a healthcare company’s reach.

Marketing 98

Marketing Media Digital Media Healthcare 98

Legacy MEDSearch

JULY 6, 2022

Annalise Enterprise CXR, the world’s first comprehensive decision-support AI solution for chest X-rays, is already in clinical use at over 400 sites in Australia and the UK and accessible by one in four Australian radiologists. Formed in 2019 as a joint venture between healthcare AI platform harrison.ai

Healthcare 52

Healthcare Healthcare FDA Networking 52

Eversana Intouch

MARCH 17, 2022

Diseases that didn’t have solutions will find them in this decade. As Rohit Bhargava said, presenting non-obvious mega-trends, we too often forget the value of mastery in the age of instant knowledge. Are we willing to change our predictions? But we need to go about it differently to see that benefit.”.

Media 52

Media Marketing Pharma Healthcare 52

Pharma Marketing Network

DECEMBER 17, 2021

Lewis, Founder & CEO of eHealthcare Solutions and Tap Native, offers his top ten predictions for what’s ahead for pharma in 2022. While large corporations with mega campuses will start to “return to campus” in 2022, if they haven’t already, few are drawing hard lines around a full-time return. In this article, R.J.

Pharma 105

Pharma Marketing Engineering Digital Media 105